Tilt Biotherapeutics

Developer of oncolytic viral immunotherapies for solid tumors

placeHelsinki, Uusimaa, Finland calendar_todayFounded 2013 groups21 employees language tiltbio.com

Registered entities

Social engagement

Social engagement: 4.4K social following, 8 posts in the last 12 months — below the industry typical range.

Investor mix

10 investors on record; lead investors include EIC Fund, Stephen Industries, Lifeline Ventures, European Innovation Council.

Investor typeCountShare
Venture capital440%
Private equity220%
Accelerator & incubator110%
Other / undisclosed330%

Recent activity

3 Jun 2026
Leadership hire
Board of Directors
29 May 2026
Event
2026 ASCO Annual Meeting
9 Dec 2025
Event
ESMO-IO IO
Coming soon